{"id":"triaziquone","rwe":[],"tags":[{"label":"triaziquone","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"L01AC02","category":"atc"},{"label":"Active","category":"status"},{"label":"Alkylating Agents","category":"pharmacology"},{"label":"Antineoplastic Agents","category":"pharmacology"},{"label":"Antineoplastic Agents, Alkylating","category":"pharmacology"},{"label":"Noxae","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"triaziquon","offLabel":[],"synonyms":["triaziquone","triaziquinone","triaziquinonum","triaziquon"],"timeline":[],"approvals":[],"brandName":"Triaziquon","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"triaziquone","explanation":"Imagine triaziquone as a key that fits into a lock on a cell. When it binds to this lock, it triggers a series of events that ultimately lead to the desired therapeutic outcome. However, the exact details of how triaziquone interacts with its target and the downstream effects are not yet fully understood.","oneSentence":"Triaziquone works by interacting with a specific cellular target to produce its therapeutic effects.","technicalDetail":"Triaziquone is a small molecule that likely binds to a specific protein or receptor, altering its function and leading to changes in cellular behavior. The exact molecular details of this interaction are unknown, but it is thought to involve a combination of covalent and non-covalent binding interactions."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4372","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TRIAZIQUONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T16:02:08.598940","biosimilars":[],"competitors":[{"drugName":"thiotepa","drugSlug":"thiotepa","fdaApproval":"1959-03-09","patentExpiry":"May 31, 2037","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"triaziquone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"thiotepa","brandName":"thiotepa","genericName":"thiotepa","approvalYear":"1959","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"F3D5D9P25I","CHEBI":"CHEBI:27090","INN_ID":"1720","UMLSCUI":"C0040878","ChEMBL_ID":"CHEMBL313302","KEGG_DRUG":"D07254","DRUGBANK_ID":"DB13304","PUBCHEM_CID":"6235","MESH_DESCRIPTOR_UI":"D014228"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":62,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"L01AC02","allCodes":["L01AC02"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triaziquon is a small molecule. It is also known by various synonyms, including BAYER 3231, RIKER 601, and NSC-29215.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}